Pollard A, Paolillo V, Radaram B, Qureshy S, Li L, Maity T
Mol Imaging Biol. 2022; 24(6):959-972.
PMID: 35732988
PMC: 9681699.
DOI: 10.1007/s11307-022-01747-9.
Zacharias N, Wang L, Maity T, Li L, Millward S, Karam J
Int J Mol Sci. 2021; 22(6).
PMID: 33799686
PMC: 8001211.
DOI: 10.3390/ijms22062849.
Ahamed F, van Criekinge M, Wang Z, Kurhanewicz J, Larson P, Sriram R
NMR Biomed. 2021; 34(3):e4467.
PMID: 33415771
PMC: 8423093.
DOI: 10.1002/nbm.4467.
Liu Y, Pang Y, Zhu B, Uher O, Caisova V, Huynh T
Clin Cancer Res. 2020; 26(14):3868-3880.
PMID: 32152203
PMC: 7443979.
DOI: 10.1158/1078-0432.CCR-19-2335.
Sobczuk P, Brodziak A, Khan M, Chhabra S, Fiedorowicz M, Welniak-Kaminska M
Transl Oncol. 2020; 13(3):100745.
PMID: 32092671
PMC: 7036425.
DOI: 10.1016/j.tranon.2020.100745.
HIF-independent synthetic lethality between CDK4/6 inhibition and VHL loss across species.
Nicholson H, Tariq Z, Housden B, Jennings R, Stransky L, Perrimon N
Sci Signal. 2019; 12(601).
PMID: 31575731
PMC: 6913182.
DOI: 10.1126/scisignal.aay0482.
Choosing the right cell line for renal cell cancer research.
Brodaczewska K, Szczylik C, Fiedorowicz M, Porta C, Czarnecka A
Mol Cancer. 2016; 15(1):83.
PMID: 27993170
PMC: 5168717.
DOI: 10.1186/s12943-016-0565-8.
Separation of extra- and intracellular metabolites using hyperpolarized (13)C diffusion weighted MR.
Koelsch B, Sriram R, Keshari K, Swisher C, van Criekinge M, Sukumar S
J Magn Reson. 2016; 270:115-123.
PMID: 27434780
PMC: 5448422.
DOI: 10.1016/j.jmr.2016.07.002.
Real-time measurement of hyperpolarized lactate production and efflux as a biomarker of tumor aggressiveness in an MR compatible 3D cell culture bioreactor.
Sriram R, van Criekinge M, Hansen A, Wang Z, Vigneron D, Wilson D
NMR Biomed. 2015; 28(9):1141-9.
PMID: 26202449
PMC: 4537810.
DOI: 10.1002/nbm.3354.
Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration.
von Roemeling C, Marlow L, Radisky D, Rohl A, Larsen H, Wei J
Oncotarget. 2014; 5(14):5320-34.
PMID: 24979721
PMC: 4170622.
DOI: 10.18632/oncotarget.2097.
Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4.
von Roemeling C, Radisky D, Marlow L, Cooper S, Grebe S, Anastasiadis P
Cancer Res. 2014; 74(17):4796-810.
PMID: 24962026
PMC: 4154999.
DOI: 10.1158/0008-5472.CAN-14-0210.
Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts.
Wang X, Zhang L, ONeill A, Bahamon B, Alsop D, Mier J
Br J Cancer. 2013; 108(2):319-26.
PMID: 23322198
PMC: 3566808.
DOI: 10.1038/bjc.2012.591.
Hyperpolarized 13C-pyruvate magnetic resonance reveals rapid lactate export in metastatic renal cell carcinomas.
Keshari K, Sriram R, Koelsch B, van Criekinge M, Wilson D, Kurhanewicz J
Cancer Res. 2012; 73(2):529-38.
PMID: 23204238
PMC: 3548990.
DOI: 10.1158/0008-5472.CAN-12-3461.
Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition.
Bray K, Mathew R, Lau A, Kamphorst J, Fan J, Chen J
PLoS One. 2012; 7(7):e41831.
PMID: 22848625
PMC: 3406086.
DOI: 10.1371/journal.pone.0041831.
Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene.
Shen C, Beroukhim R, Schumacher S, Zhou J, Chang M, Signoretti S
Cancer Discov. 2011; 1(3):222-35.
PMID: 22037472
PMC: 3202343.
DOI: 10.1158/2159-8290.CD-11-0098.
Type III transforming growth factor-beta (TGF-beta) receptor mediates apoptosis in renal cell carcinoma independent of the canonical TGF-beta signaling pathway.
Margulis V, Maity T, Zhang X, Cooper S, Copland J, Wood C
Clin Cancer Res. 2008; 14(18):5722-30.
PMID: 18794080
PMC: 2844539.
DOI: 10.1158/1078-0432.CCR-08-0546.
Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells.
Gorospe M, Egan J, Zbar B, Lerman M, Geil L, Kuzmin I
Mol Cell Biol. 1999; 19(2):1289-300.
PMID: 9891063
PMC: 116058.
DOI: 10.1128/MCB.19.2.1289.
Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes.
Ivanov S, Kuzmin I, Wei M, Pack S, Geil L, Johnson B
Proc Natl Acad Sci U S A. 1998; 95(21):12596-601.
PMID: 9770531
PMC: 22876.
DOI: 10.1073/pnas.95.21.12596.
Chromophilic renal cell carcinoma: cytomorphological and cytogenetic characterisation of four permanent cell lines.
Gerharz C, Hildebrandt B, Moll R, Ramp U, Sarbia M, Storkel S
Br J Cancer. 1996; 74(10):1605-14.
PMID: 8932342
PMC: 2074836.
DOI: 10.1038/bjc.1996.596.
Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro.
Gerharz C, Moll R, Storkel S, Ramp U, Thoenes W, Gabbert H
Am J Pathol. 1993; 142(3):851-9.
PMID: 7681259
PMC: 1886798.